InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Viking Therapeutics, Inc.

VKTX Clue Score32
United States Fiscal year ends December CIK 0001607678 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

125
Insider
Date
Role
Action
Shares
Price
Amount
Marianna Mancini
29 Jul 2026
Chief Operating Officer
Sell
18,217
$33.47
$609.64K
Greg Zante
29 Jul 2026
Chief Financial Officer
Sell
21,217
$33.47
$710.14K
Brian Lian
29 Jul 2026
President & CEO
Sell
148,517
$33.32
$4.95M
Neil William Aubuchon
10 Mar 2026
Chief Commercial Officer
Buy
4,475
$33.50
$149.91K
Brian Lian
5 Jan 2026
President & CEO
Sell
6,400
$35.07
$224.42K
Brian Lian
5 Jan 2026
President & CEO
Sell
41,276
$34.22
$1.41M
Brian Lian
5 Jan 2026
President & CEO
Sell
53,279
$33.38
$1.78M
Brian Lian
5 Jan 2026
President & CEO
Sell
132,454
$32.29
$4.28M
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
1,600
$35.07
$56.12K
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
10,500
$34.22
$359.30K
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
13,600
$33.37
$453.88K
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
31,961
$32.29
$1.03M
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
1,500
$32.09
$48.13K
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
10,300
$34.24
$352.63K
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
13,900
$33.38
$464.02K
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
31,961
$32.30
$1.03M
Matthew W Foehr
2 Jan 2026
Director
Sold after exercise
16,000
$35.11
$561.69K
Greg Zante
28 Oct 2025
Chief Financial Officer
Sell
6,185
$35.00
$216.48K
Brian Lian
28 Oct 2025
President & CEO
Sell
38,989
$35.01
$1.36M
Marianna Mancini
28 Oct 2025
Chief Operating Officer
Sell
6,185
$35.00
$216.49K
Charles A Rowland Jr
27 Oct 2025
Director
Sold after exercise
60,000
$35.57
$2.13M
Marianna Mancini
3 Jul 2025
Chief Operating Officer
Sell
4,266
$27.77
$118.47K
Greg Zante
3 Jul 2025
Chief Financial Officer
Sell
4,266
$27.76
$118.43K
Brian Lian
3 Jul 2025
President & CEO
Sell
26,889
$27.80
$747.63K
Matthew W Foehr
11 Apr 2025
Director
Exercised, kept
20,786
$8.00
$166.29K
Sarah Kathryn Rouan
31 Mar 2025
Director
Buy
1,240
$24.15
$29.94K
Greg Zante
6 Jan 2025
Chief Financial Officer
Sell
4,700
$43.32
$203.60K
Greg Zante
6 Jan 2025
Chief Financial Officer
Sell
45,609
$42.69
$1.95M
Marianna Mancini
6 Jan 2025
Chief Operating Officer
Sell
5,100
$43.32
$220.91K
Marianna Mancini
6 Jan 2025
Chief Operating Officer
Sell
49,115
$42.69
$2.10M
Brian Lian
6 Jan 2025
President & CEO
Sell
19,000
$43.32
$823.02K
Brian Lian
6 Jan 2025
President & CEO
Sell
175,490
$42.68
$7.49M
Lawson Macartney
8 Nov 2024
Director
Sold after exercise
2,000
$68.67
$137.33K
Greg Zante
28 Oct 2024
Chief Financial Officer
Sold after exercise
1,206
$81.44
$98.22K
Greg Zante
28 Oct 2024
Chief Financial Officer
Sold after exercise
7,967
$80.65
$642.54K
Greg Zante
28 Oct 2024
Chief Financial Officer
Sold after exercise
6,050
$79.78
$482.66K
Greg Zante
28 Oct 2024
Chief Financial Officer
Sold after exercise
15,825
$78.69
$1.25M
Greg Zante
28 Oct 2024
Chief Financial Officer
Sold after exercise
23,082
$77.68
$1.79M
Greg Zante
28 Oct 2024
Chief Financial Officer
Sold after exercise
9,265
$76.94
$712.80K
Greg Zante
28 Oct 2024
Chief Financial Officer
Sold after exercise
18,620
$75.79
$1.41M
Greg Zante
28 Oct 2024
Chief Financial Officer
Sold after exercise
49,672
$74.56
$3.70M
J Matthew Singleton
25 Oct 2024
Director
Sold after exercise
16,000
$79.50
$1.27M
Sarah Kathryn Rouan
25 Oct 2024
Director
Sold after exercise
11,000
$80.89
$889.79K
Brian Lian
20 Sep 2024
President & CEO
Sold after exercise
200
$71.99
$14.40K
Brian Lian
20 Sep 2024
President & CEO
Sold after exercise
119,874
$71.15
$8.53M
Brian Lian
20 Sep 2024
President & CEO
Sold after exercise
96,056
$70.43
$6.77M
J Matthew Singleton
20 Sep 2024
Director
Sold after exercise
10,300
$69.50
$715.85K
J Matthew Singleton
21 Aug 2024
Director
Sold after exercise
5,700
$69.72
$397.43K
Brian Lian
21 Aug 2024
President & CEO
Sold after exercise
1,000
$69.90
$69.90K
J Matthew Singleton
19 Aug 2024
Director
Sold after exercise
1,501
$64.88
$97.38K
J Matthew Singleton
19 Aug 2024
Director
Sold after exercise
2,388
$64.10
$153.08K
J Matthew Singleton
19 Aug 2024
Director
Sold after exercise
2,055
$63.15
$129.78K
J Matthew Singleton
19 Aug 2024
Director
Sold after exercise
4,509
$61.86
$278.93K
J Matthew Singleton
19 Aug 2024
Director
Sold after exercise
3,047
$61.13
$186.25K
J Matthew Singleton
19 Aug 2024
Director
Sold after exercise
2,500
$60.01
$150.03K
Brian Lian
19 Aug 2024
President & CEO
Sold after exercise
11,296
$67.12
$758.19K
Brian Lian
19 Aug 2024
President & CEO
Sold after exercise
31,442
$66.37
$2.09M
Brian Lian
19 Aug 2024
President & CEO
Sold after exercise
70,132
$65.33
$4.58M
J Matthew Singleton
14 Aug 2024
Director
Sold after exercise
160
$58.37
$9.34K
J Matthew Singleton
14 Aug 2024
Director
Sold after exercise
20,626
$57.52
$1.19M
Marianna Mancini
30 Jul 2024
Chief Operating Officer
Sell
3,322
$57.82
$192.08K
Marianna Mancini
30 Jul 2024
Chief Operating Officer
Sell
14,704
$56.98
$837.83K
Brian Lian
30 Jul 2024
President & CEO
Sell
30,417
$58.78
$1.79M
Brian Lian
30 Jul 2024
President & CEO
Sell
19,501
$57.81
$1.13M
Brian Lian
30 Jul 2024
President & CEO
Sell
65,941
$56.95
$3.76M
Greg Zante
30 Jul 2024
Chief Financial Officer
Sell
500
$58.71
$29.36K
Greg Zante
30 Jul 2024
Chief Financial Officer
Sell
2,974
$57.71
$171.63K
Greg Zante
30 Jul 2024
Chief Financial Officer
Sell
12,662
$56.96
$721.23K
Greg Zante
3 May 2024
Chief Financial Officer
Sold after exercise
847
$76.07
$64.43K
Greg Zante
3 May 2024
Chief Financial Officer
Sold after exercise
17,238
$75.49
$1.30M
Greg Zante
3 May 2024
Chief Financial Officer
Sold after exercise
45,570
$74.44
$3.39M
Greg Zante
3 May 2024
Chief Financial Officer
Sold after exercise
3,101
$73.49
$227.89K
Marianna Mancini
1 May 2024
Chief Operating Officer
Sold after exercise
6,248
$80.08
$500.31K
Marianna Mancini
1 May 2024
Chief Operating Officer
Sold after exercise
119,946
$79.29
$9.51M
Marianna Mancini
1 May 2024
Chief Operating Officer
Sold after exercise
105,343
$78.65
$8.28M
Marianna Mancini
1 May 2024
Chief Operating Officer
Sold after exercise
26,142
$77.49
$2.03M
Marianna Mancini
1 May 2024
Chief Operating Officer
Sold after exercise
23,746
$76.40
$1.81M
Brian Lian
9 Feb 2024
President & CEO
Sold on a plan
45,000
$29.90
$1.35M
Sarah Kathryn Rouan
8 Feb 2024
Director
Sold after exercise
25,000
$28.05
$701.25K
Brian Lian
8 Feb 2024
President & CEO
Sold after exercise
40,000
$28.90
$1.16M
Brian Lian
8 Feb 2024
President & CEO
Sold after exercise
40,000
$27.45
$1.10M
Brian Lian
8 Feb 2024
President & CEO
Sold after exercise
80,000
$26.95
$2.16M
Brian Lian
8 Feb 2024
President & CEO
Sold after exercise
60,000
$25.95
$1.56M
Brian Lian
8 Feb 2024
President & CEO
Sold after exercise
49,079
$25.75
$1.26M
Brian Lian
31 Jan 2024
President & CEO
Sold after exercise
45,000
$24.95
$1.12M
Brian Lian
31 Jan 2024
President & CEO
Sold after exercise
40,000
$24.45
$978.00K
Brian Lian
30 Jan 2024
President & CEO
Sold after exercise
35,000
$23.95
$838.25K
Sarah Kathryn Rouan
19 Jan 2024
Director
Sold after exercise
30,000
$23.05
$691.50K
Greg Zante
4 Jan 2024
Chief Financial Officer
Sell
15,000
$17.90
$268.50K
Lawson Macartney
16 May 2023
Director
Sold after exercise
16,000
$24.00
$384.00K
Charles A Rowland Jr
16 May 2023
Director
Sold after exercise
40,000
$25.00
$1.00M
Brian Lian
1 May 2023
President & CEO
Sell
45,000
$22.45
$1.01M
Lawson Macartney
24 Apr 2023
Director
Sold after exercise
16,000
$22.00
$352.06K
Brian Lian
19 Apr 2023
President & CEO
Sell
35,000
$21.45
$750.75K
Greg Zante
17 Apr 2023
Chief Financial Officer
Sold after exercise
7,500
$20.00
$150.00K
Marianna Mancini
17 Apr 2023
Chief Operating Officer
Sold after exercise
12,500
$20.00
$250.00K
Brian Lian
17 Apr 2023
President & CEO
Sold after exercise
155,000
$20.45
$3.17M
Lawson Macartney
17 Apr 2023
Director
Sold after exercise
20,786
$20.00
$415.72K
Brian Lian
13 Apr 2023
President & CEO
Sold after exercise
79,336
$18.45
$1.46M
Greg Zante
12 Apr 2023
Chief Financial Officer
Sold after exercise
41,544
$18.00
$747.79K
Greg Zante
11 Apr 2023
Chief Financial Officer
Sold after exercise
56,295
$18.00
$1.01M
Greg Zante
3 Apr 2023
Chief Financial Officer
Sold after exercise
30,911
$18.00
$556.40K
Brian Lian
3 Apr 2023
President & CEO
Sell
22,000
$17.85
$392.70K
Brian Lian
31 Mar 2023
President & CEO
Sold after exercise
67,970
$17.45
$1.19M
Marianna Mancini
30 Mar 2023
Chief Operating Officer
Exercised, kept
3,000
$6.47
$19.41K
Marianna Mancini
30 Mar 2023
Chief Operating Officer
Exercised, kept
10,000
$7.69
$76.90K
Marianna Mancini
30 Mar 2023
Chief Operating Officer
Exercised, kept
23,100
$8.52
$196.81K
Greg Zante
30 Mar 2023
Chief Financial Officer
Sold after exercise
131,029
$17.00
$2.23M
Brian Lian
30 Mar 2023
President & CEO
Sold after exercise
65,382
$17.45
$1.14M
Brian Lian
30 Mar 2023
President & CEO
Sold after exercise
88,000
$16.95
$1.49M
Marianna Mancini
29 Mar 2023
Chief Operating Officer
Sold after exercise
41,242
$16.00
$659.87K
Marianna Mancini
28 Mar 2023
Chief Operating Officer
Sold after exercise
196,563
$15.00
$2.95M
Matthew W Foehr
2 May 2022
Director
Buy
45,000
$2.47
$111.20K
Matthew W Foehr
10 Jun 2021
Director
Buy
20,000
$5.69
$113.80K
Matthew W Foehr
22 Mar 2021
Director
Exercised, kept
20,000
$1.50
$30.00K
Ligand Pharmaceuticals Inc
26 Aug 2020
10% owner
Sell
94,488
$8.11
$766.11K
Ligand Pharmaceuticals Inc
25 Aug 2020
10% owner
Sell
70,000
$8.02
$561.58K
Matthew W Foehr
30 Jun 2020
Director
Sell
13,000
$7.35
$95.55K
Ligand Pharmaceuticals Inc
25 Sep 2018
10% owner
Sell
262,881
$19.15
$5.03M
Michael Morneau
31 May 2018
VP, Finance and Administration
Sell
21,551
$9.25
$199.35K
J Matthew Singleton
31 May 2018
Director
Buy
9,500
$9.82
$93.26K
Lawson Macartney
29 May 2018
Director
Buy
47,965
$5.22
$250.33K
Stephen W Webster
29 May 2018
Director
Buy
8,000
$5.21
$41.71K
Charles A Rowland Jr
29 May 2018
Director
Buy
30,000
$5.16
$154.80K
Matthew W Foehr
15 Nov 2016
Director
Buy
13,000
$1.21
$15.68K

What was left out

Form 4 filings counted 173
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 66
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 8,612,884
Sales filed before the plan box existed 5
History held since 30 Apr 2015